Grünenthal is passionate about globally being the preferred partner in pain management for patients, health care professionals and payors. The corporation drives innovation to expand European market leadership in moderate to severe pain. Grünenthal is an independent, family-owned German corporation with companies in 34 countries all over the world. Founded in 1946, the corporation employs 2,000 people in Germany and 5,200 worldwide. In 2008, Grünenthal achieved revenues of about 864 million Euros.

Together with highly specialised partners we are pressing on with the research and development of new active substances. For this we are concentrating on selected indications and the latest technological developments. We are intensively searching for innovative ways of improving pain, pain relief and reducing side-effects.

Member of the German
Association of Research-Based
Pharmaceutical Companies